Xiamen Voke Mold & Plastic Engineering Co (301196) Fair Value & Analysis
Industrials · CN · Market cap 25.1B CNY
Analysis
Xiamen Voke Mold & Plastic Engineering Co (301196) currently trades at ¥209.28, while our model-based Fair Value estimate is ¥42.71 — implying the stock looks roughly 79.6% overvalued today. We read business quality at 93/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Xiamen Voke Mold & Plastic Engineering Co., Ltd. engages in the research, development, design, manufacture, and sale of various injection molds in China and internationally. It provides car central housing control, car air outlet housing, grille, engine connection body, air outlet high-gloss panel, car button two-color mold, six fuel tank two-color housing, car panel housing, steering wheel airbag, car dashboard housing, automobile instrument internal structural parts housing, car glove box housing, and automobile electric tailgate spring sleeve, used in automotive field. It also provides electronic cigarette shell, pen cap, micro injection - hearing aid, optical cable communication shell, electronic connector, and 5G communication base station cooling fan products for use in electronic field; tool box, insulation box, multi-cavity cosmetic mold, baby carriage decorative cover shell, and baby wheel hub housing products used in home filed; and analysis box shell, medical laryngeal ma…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.